OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab
Maria di Giamberardino, Giannapia Affaitati, Raffaele Costantini, et al.
Journal of Pain Research (2017) Vol. Volume 10, pp. 2751-2760
Open Access | Times Cited: 41
Maria di Giamberardino, Giannapia Affaitati, Raffaele Costantini, et al.
Journal of Pain Research (2017) Vol. Volume 10, pp. 2751-2760
Open Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
Therapeutic novelties in migraine: new drugs, new hope?
Thien Phu, Song Guo, Messoud Ashina
The Journal of Headache and Pain (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 111
Thien Phu, Song Guo, Messoud Ashina
The Journal of Headache and Pain (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 111
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study
Bianca Raffaelli, Rea Kalantzis, Jasper Mecklenburg, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 79
Bianca Raffaelli, Rea Kalantzis, Jasper Mecklenburg, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 79
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study
Taoufik Alsaadi, Reem Suliman, Vanessa Santos, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 2, pp. 465-473
Open Access | Times Cited: 11
Taoufik Alsaadi, Reem Suliman, Vanessa Santos, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 2, pp. 465-473
Open Access | Times Cited: 11
The CGRP Pathway in Migraine as a Viable Target for Therapies
Lars Edvinsson
Headache The Journal of Head and Face Pain (2018) Vol. 58, Iss. S1, pp. 33-47
Open Access | Times Cited: 81
Lars Edvinsson
Headache The Journal of Head and Face Pain (2018) Vol. 58, Iss. S1, pp. 33-47
Open Access | Times Cited: 81
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies
Damiana Scuteri, Annagrazia Adornetto, Laura Rombolà, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 69
Damiana Scuteri, Annagrazia Adornetto, Laura Rombolà, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 69
Co-occurrence of pain syndromes
Giannapia Affaitati, Raffaele Costantini, Claudio Tana, et al.
Journal of Neural Transmission (2019) Vol. 127, Iss. 4, pp. 625-646
Closed Access | Times Cited: 61
Giannapia Affaitati, Raffaele Costantini, Claudio Tana, et al.
Journal of Neural Transmission (2019) Vol. 127, Iss. 4, pp. 625-646
Closed Access | Times Cited: 61
Acute headache management in emergency department. A narrative review
Maria Adele Giamberardino, Giannapia Affaitati, Raffaele Costantini, et al.
Internal and Emergency Medicine (2020) Vol. 15, Iss. 1, pp. 109-117
Closed Access | Times Cited: 52
Maria Adele Giamberardino, Giannapia Affaitati, Raffaele Costantini, et al.
Internal and Emergency Medicine (2020) Vol. 15, Iss. 1, pp. 109-117
Closed Access | Times Cited: 52
Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
Hugo Sevivas, Paula Fresco
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 30
Hugo Sevivas, Paula Fresco
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 30
Erenumab and OnabotulinumtoxinA Combination Therapy for the Prevention of Intractable Chronic Migraine without Aura: A Retrospective Analysis
Mark Armanious, Nadia Khalil, Yuanyuan Lu, et al.
Journal of Pain & Palliative Care Pharmacotherapy (2020) Vol. 35, Iss. 1, pp. 1-6
Closed Access | Times Cited: 48
Mark Armanious, Nadia Khalil, Yuanyuan Lu, et al.
Journal of Pain & Palliative Care Pharmacotherapy (2020) Vol. 35, Iss. 1, pp. 1-6
Closed Access | Times Cited: 48
Safety and tolerability of calcitonin-gene-related peptide binding monoclonal antibodies for the prevention of episodic migraine – a meta-analysis of randomized controlled trials
Da Xu, Deng Chen, Lina Zhu, et al.
Cephalalgia (2019) Vol. 39, Iss. 9, pp. 1164-1179
Closed Access | Times Cited: 46
Da Xu, Deng Chen, Lina Zhu, et al.
Cephalalgia (2019) Vol. 39, Iss. 9, pp. 1164-1179
Closed Access | Times Cited: 46
A review of antibody-based therapeutics targeting G protein-coupled receptors: an update
Catherine J. Hutchings
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 8, pp. 925-935
Closed Access | Times Cited: 42
Catherine J. Hutchings
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 8, pp. 925-935
Closed Access | Times Cited: 42
Update on GPCR-based targets for the development of novel antidepressants
Ioannis Mantas, Marcus Saarinen, Qing Xu, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 534-558
Open Access | Times Cited: 36
Ioannis Mantas, Marcus Saarinen, Qing Xu, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 534-558
Open Access | Times Cited: 36
CGRP Antagonists for the Treatment of Chronic Migraines: a Comprehensive Review
Ivan Urits, Mark R. Jones, Kyle Gress, et al.
Current Pain and Headache Reports (2019) Vol. 23, Iss. 5
Closed Access | Times Cited: 40
Ivan Urits, Mark R. Jones, Kyle Gress, et al.
Current Pain and Headache Reports (2019) Vol. 23, Iss. 5
Closed Access | Times Cited: 40
Migraine Aura: Pathophysiology, Mimics, and Treatment Options
Clare L. Fraser, Jenny L. Hepschke, Bronwyn Jenkins, et al.
Seminars in Neurology (2019) Vol. 39, Iss. 06, pp. 739-748
Closed Access | Times Cited: 39
Clare L. Fraser, Jenny L. Hepschke, Bronwyn Jenkins, et al.
Seminars in Neurology (2019) Vol. 39, Iss. 06, pp. 739-748
Closed Access | Times Cited: 39
Dawn of a New RAMPage
Donald Serafín, Natalie R. Harris, Natalie R. Nielsen, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 4, pp. 249-265
Open Access | Times Cited: 35
Donald Serafín, Natalie R. Harris, Natalie R. Nielsen, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 4, pp. 249-265
Open Access | Times Cited: 35
The Transient Receptor Potential Ankyrin Type 1 Plays a Critical Role in Cortical Spreading Depression
Liwen Jiang, Yan Wang, Yuewei Xu, et al.
Neuroscience (2018) Vol. 382, pp. 23-34
Closed Access | Times Cited: 33
Liwen Jiang, Yan Wang, Yuewei Xu, et al.
Neuroscience (2018) Vol. 382, pp. 23-34
Closed Access | Times Cited: 33
Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence—What Do We Know So Far?
Theodorοs Mavridis, Christina Deligianni, Georgios Karagiorgis, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 700-700
Open Access | Times Cited: 23
Theodorοs Mavridis, Christina Deligianni, Georgios Karagiorgis, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 700-700
Open Access | Times Cited: 23
CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
Matilde Capi, Valerio De Angelis, Donatella De Bernardini, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 7, pp. 1429-1429
Open Access | Times Cited: 22
Matilde Capi, Valerio De Angelis, Donatella De Bernardini, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 7, pp. 1429-1429
Open Access | Times Cited: 22
Calcitonin-gene-related peptide pathway mAbs and migraine prevention
Koen Paemeleire, Antoinette MaassenVanDenBrink
Current Opinion in Neurology (2018) Vol. 31, Iss. 3, pp. 274-280
Closed Access | Times Cited: 25
Koen Paemeleire, Antoinette MaassenVanDenBrink
Current Opinion in Neurology (2018) Vol. 31, Iss. 3, pp. 274-280
Closed Access | Times Cited: 25
Advances in orally administered pharmacotherapy for the treatment of migraine
Paolo Martelletti, Maria Adele Giamberardino
Expert Opinion on Pharmacotherapy (2018) Vol. 20, Iss. 2, pp. 209-218
Closed Access | Times Cited: 25
Paolo Martelletti, Maria Adele Giamberardino
Expert Opinion on Pharmacotherapy (2018) Vol. 20, Iss. 2, pp. 209-218
Closed Access | Times Cited: 25
Graphene as a potential treatment for acute migraine: A computational study
Sima Rezvantalab, Aylar Imanpour, Abdolvahab Seif
Materials Today Communications (2024) Vol. 38, pp. 108024-108024
Closed Access | Times Cited: 2
Sima Rezvantalab, Aylar Imanpour, Abdolvahab Seif
Materials Today Communications (2024) Vol. 38, pp. 108024-108024
Closed Access | Times Cited: 2
Erenumab is effective in reducing migraine frequency and improving physical functioning
Paolo Martelletti
BMJ evidence-based medicine (2018) Vol. 24, Iss. 2, pp. 76-76
Open Access | Times Cited: 16
Paolo Martelletti
BMJ evidence-based medicine (2018) Vol. 24, Iss. 2, pp. 76-76
Open Access | Times Cited: 16
New Therapeutic Options for Migraine
Claudio Tana, Francesco Cipollone, Maria Adele Giamberardino
Current Pharmaceutical Design (2023) Vol. 29, Iss. 25, pp. 1964-1966
Closed Access | Times Cited: 4
Claudio Tana, Francesco Cipollone, Maria Adele Giamberardino
Current Pharmaceutical Design (2023) Vol. 29, Iss. 25, pp. 1964-1966
Closed Access | Times Cited: 4
Effects of topical vs injection treatment of cervical myofascial trigger points on headache symptoms in migraine patients: a retrospective analysis
Giannapia Affaitati, Raffaele Costantini, Claudio Tana, et al.
The Journal of Headache and Pain (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 12
Giannapia Affaitati, Raffaele Costantini, Claudio Tana, et al.
The Journal of Headache and Pain (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 12
A proof-of-concept study on CGRP plasma levels of migraineurs during a 6-month treatment with ERENUMAB
Giuseppe Tringali, Catello Vollono, Paolo Calabresi, et al.
The Journal of Headache and Pain (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Giuseppe Tringali, Catello Vollono, Paolo Calabresi, et al.
The Journal of Headache and Pain (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 10
